Hot Issues in Reissue Patent Litigation

Ms. Stein is an IP litigator who focuses her practice on intellectual property disputes, primarily in the patent and trademark areas.

Ms. Stein has extensive experience litigating a broad variety of patent infringement and other matters in the pharmaceuticals and life science area, including matters related to antibiotics, anti-depressants, anti-coagulants, epilepsy, pain, ADHD, sleep apnea, and high blood pressure medications, and SABAs used to treat asthma and/or COPD. Ms. Stein also has substantial experience litigating patent infringement disputes in the non-pharma area, including related to GPS devices, gaming, hand-held devices and packaging.

Ms. Stein has appeared before federal and state courts throughout the United States, including New York, New Jersey, Delaware, Massachusetts, California, Florida, Texas, District of Columbia, Illinois, and Nebraska, and before the Court of Appeals for the D.C. and Federal Circuits, most recently obtaining a Rule 36 affirmance of five separate summary judgments concerning alleged patent infringement, false patent marking, and commercial claims.

Well-armed with undergraduate and graduate scientific degrees in biochemistry, chemistry, and genetics/cell biology, Mr. Stimart focuses his practice on intellectual property litigation in district courts and the USPTO in the fields of pharmaceuticals, biopharmaceuticals, biotechnology, medical diagnostics, and biofuels, as well as computer software and video compression technology. He regularly advises clients on intellectual property pre-litigation strategies, inter partes reviews, due diligence and opinion work, licensing, merger and acquisitions, and strategic intellectual property counseling.

Mr. Stimart also brings unique experience and a distinctly relevant perspective that will greatly benefit the firm's clients. Prior to his legal career, he was an Advisor with the Advanced Technology Program at the National Institute of Standards and Technology (NIST), where he was a program manager and reviewed complex technical proposals on cutting-edge technology that involved any use of humans or animals in research. Mr. Stimart represented the United States Department of Commerce, on a federal level, as part of the Human Research Protections Program and earned a Bronze Medal for superior performance concerning the use of human embryonic stem cells.

Mr. Stimart is a former United States Naval Officer, serving on active duty, as well as the reserves.